Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Golimumab (atc Code According To Who 2025-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Tocilizumab (atc Code According To Who 2025-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Bosutinib  2025-12-31
Germany Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Bosutinib (atc-code Nach Who: L01ea04) 2025-12-31
Germany Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Golimumab (atc-code Nach Who: L04ab06) 2025-12-31
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Tocilizumab (atc Code According To Who: L04ac07) 2025-12-31
Germany Pazopanib (strength 200mg) 2025-12-31
Germany Pazopanib (strength 400mg) 2025-12-31
Germany Openhouseoriginalerabattverträge 202415 Pazopanib 2025-12-31
Ethiopia Ethiopia Pharmaceutical Supplies Service Invites Eligible Bidders For The Procurement Of Tb Kit 2025-12-31
Whats app